India’s Jubilant Life Sciences Ltd, Signs Licensing Deal For US Pharma Firm Gilead’s COVID-19 Drug
New Delhi: India’s Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc’s experimental COVID-19 treatment remdesivir in 127 countries, including … Read More